pexels pavel danilyuk 8381923

Biopharma’s Brave New Biology

The Medicine Maker – January 2016 – We live in exciting times for the biopharma industry. The 100-year-old promise of cancer immunotherapy turning cancer into a chronic (if not curable) disease seems within reach in selected indications. …